vision study

177Lu-PSMA-617 radioligand therapy in mCRPC – VISION phase 3 trial The results from the “ProPSMA” Study, that was recently published in JAMA Oncology by Prof.

Read More »
proPSMA studies - Isotopia

proPSMA study

The “proPSMA” study results proved the superiority of 68Ga-PSMA imaging over conventional imaging with CT and Bone Scan in Prostate Cancer Results from a randomised

Read More »
18f dopa use in parkinsonism - Isotopia

18F-DOPA use in Parkinsonism On October 10, 2019, the FDA approved the use of 18F-DOPA in positron emission tomography to visualize dopaminergic nerve terminals in the striatum for

Read More »
metastatic prostate cancer treatment - Isotopia

Prostate cancer

Innovative metastatic prostate cancer treatment with 177-Lu-PSMA. Prostate cancer is the most common cancer in older men (over 50) and the second cause of cancer death in

Read More »